全球合成生物学市场 – 行业趋势及 2029 年预测

市场分析和规模

合成生物学是一种环境友好型技术，已在危险清理项目中得到广泛应用，包括利用合成微生物来消化二恶英、杀虫剂甚至放射性物质等难降解物质。合成生物学有助于稳定医疗行业的价格增长，从而推动该市场的需求。DNA 合成技术和成簇的规律间隔短回文重复序列方法有助于降低癌症和糖尿病等慢性疾病的发病率。生物医学、制药、农业、生物燃料和化学工业都是该技术的主要用户。农民可以利用合成生物学在更小的土地上种植更多的作物，而且它比以前的基因技术更准确、更完美。

Data Bridge Market Research 分析认为，2021 年合成生物学市场规模为 95 亿美元，到 2029 年将飙升至 488.1 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 22.70%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分

Market Definition

Synthetic biology combines engineering and science to create unique biological systems with practical applications. Synthetic biology is the process of creating new biological units such as cells, enzymes, and genetic circuits and modifying existing biological systems. Synthetic biology's primary goal is to create new biological components that do not exist in nature, such as advanced biofuels, renewable chemicals, and bio goods. Synthetic biology discovers standardised genomic units that can be utilised to quickly synthesize and assemble small genomic parts into integrated large systems to tackle specific biological difficulties for the development of biological systems.

Synthetic Biology Market Dynamics

Drivers

• Increase in synthetic drugs and vaccines

The market is predicted to expand as demand for protein therapies and personalised medicine grows and research into synthetic pharmaceuticals and vaccines. Other factors such as increased synthetic biology application, increased synthetic biology investment, lower DNA sequencing and synthesising costs, and increased R&D expenditure and activities are likely to accelerate synthetic biology market expansion during the forecast period of 2022 to 2029.

• Increased research and development funding

R&D spending in the life sciences industry climbed by 22% from 2018 to 2019, according to a Business Wire report published in September 2020. Pharmaceutical companies have received more funds for research and development in order to discover new therapies. The government has made steps to fund various pharmaceutical and biotech enterprises in order to advance pharmaceutically and boost international competitiveness. As a result, R&D spending and funding have steadily rised throughout the years. Pharmaceutical and biotechnology businesses devote significant resources to research in order to create game-changing compounds that will meet the expanding demands of the healthcare industry and tackle emerging ailments. Pharmaceutical research and development accounts for more than 80% of all R&D spending in the life sciences industry.

• Improving diagnosis and better treatment

Synthetic biology is used in the healthcare industry because it can help improve diagnostics and offer better treatment options for a variety of diseases by targeting only the disease site and creating no side effects. In addition, the use of genetically designed viruses to fix damaged genes in patients with inherited disorders such as epidermolysis bullosa or severe combined immune deficiency (SCID) has increased significantly. Aside from that, technologies for executing synthetic biology are becoming more accessible, and internet usage has facilitated free interchange of ideas and information, encouraging market expansion. Furthermore, the market is being influenced positively by significant expansion in the healthcare sector and an increase in the number of synthetic biology research units around the world.

Opportunities

• Demand for fuel alternatives

Biofuels are becoming increasingly important as fuel use rises and concerns about energy security develop. Annually, nearly 150 billion tonnes of biomass are produced worldwide. Biofuels are currently made from edible commodities such as maize, sugarcane, and vegetable oil. As a result, synthetic biology techniques are becoming more widely used in renewable energy development.

Restraints/Challenges

• Ethical and biosafety concerns

The purposeful or unintentional release of synthetic organisms into the environment during research and other purposes is the primary biosafety risk in synthetic biology. When synthetic microorganisms are released into the environment, they might mutate or interact with existing organisms, potentially causing crossbreeding and bio errors. These repercussions may pose a hazard to natural creatures' ecosystems. Additionally, the emergence of antibiotic-resistant superbugs is a huge biosecurity risk. In recent years, the European Union (EU) has supported a number of studies into the environmental impact of genetically altered bacteria released for plant growth or bioremediation. These factors may limit the market's growth in the following years.

This synthetic biology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the synthetic biology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Synthetic Biology Market

Pharmaceutical and biopharmaceutical businesses and synthetic biology market players have stepped up to help with global research efforts by providing synthetic biology for producing test kits, therapies, and vaccinations to combat coronavirus infection. A report from the European Parliament highlights synthetic biology as one of the developing technologies. It has the ability to combat the COVID-19 pandemic. The US National Institute of Health has also suggested synthetic biology as a technique to accelerate vaccine development. By employing their engineering methodologies founded on a range of data, synthetic biology technologies have the potential to alter the research and manufacture of vaccines, medicines, and diagnostics (genomic sequences, sequence annotations, enzyme properties, metabolic models, lab protocols, algorithms, and scientific knowledge). Vaccine technologies based on DNA and mRNA, for example, can make vaccine development and manufacture easier. These vaccines are made up of synthetic nucleotide strands that cause proteins to develop in the individual's own cells, triggering an immunological response. As a result of the availability of viral sequencing data, vaccination candidates can be developed quickly. This has allowed companies like Moderna and Inovio to proceed quickly into clinical development.

Recent Development

• In January 2021, Frontia GlutenEx was developed by Novozymes. It would assist wheat processors in improving gluten protein recovery while reducing energy use.
• In February 2021, Merck collaborated with BioNTech (Germany) to provide lipids for the Pfizer-BioNTech COVID-19 vaccine (BNT162b2).
• In January 2021, Merck bought AmpTec (Germany). The company expanded its product portfolio by developing and manufacturing mRNA for use in vaccinations, therapies, and diagnostics as a result of this purchase.

Global Synthetic Biology Market Scope

The synthetic biology market is segmented on the basis of tool, technology and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Tool

• Oligonucleotides and Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Synthetic Cells
• Chassis Organisms
• Xeno-nucleic Acids

Technology

• Gene Synthesis
• Genome Engineering
• Sequencing
• Bioinformatics
• Site-directed Mutagenesis
• Cloning
• Measurement and Modeling
• Microfluidics
• Nanotechnology

Application

• Medical Application
• Pharmaceuticals
• Drug Discovery and Therapeutics
• Cancer Detection and Diagnostics
• Other Drug Discovery and Therapeutic Applications
• Artificial Tissue and Tissue Regeneration
• Bio-synthesis
• Stem Cell Regulation
• Other Tissue and Tissue Regeneration Applications
• Industrial Applications
• Biofuel and Renewable Energy
• Biomaterials and Green Chemicals
• Industrial Enzymes, by Application
• Textile Industry
• Paper Industry
• Consumer Care Industry
  • Skin Care and Cosmetics
  • Other Consumer Care Products
  • Other Industries
• Food and Agriculture
• Environmental Applications
• Bioremediation
• Biosensing

Synthetic biology Market Regional Analysis/Insights

The synthetic biology market is analysed and market size insights and trends are provided by country, tool, technology and application as referenced above.

The countries covered in the synthetic biology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

 North America dominating the synthetic biology market, due to various factors such as the increase in the number of well-established synthetic biology companies and research institutes in the US and Canada.

Asia-Pacific is expected to grow the synthetic biology market in the forecast period of 2022 to 2029 due to the growing number of pharmaceutical and biopharmaceutical companies and increasing healthcare and life science facilities which is expected to improve the synthetic biology market in forecast period.

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。 

竞争格局和合成生物学市场份额分析

合成生物学市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对合成生物学市场的关注有关。

合成生物学市场的一些主要参与者包括：

• 赛默飞世尔科技公司（美国）
• 默克集团（德国）
• 安捷伦科技公司（美国）
• 诺维信（丹麦）
• Ginkgo Bioworks（美国）
• Amyris（美国）
• Precigen Inc.（美国）
• 金斯瑞 (中国)
• Twist Bioscience（美国）
• 合成基因组学（美国）
• Codexis Inc.（美国）
• Synthego（美国）
• Creative Enzymes（美国）
• Eurofins Scientific（卢森堡）
• Cyrus Biotechnology Inc.（美国）
• ATUM（美国）
• TeselaGen（美国）
• Arzeda（美国）
• Integrated DNA Technologies Inc.（美国）
• 新英格兰生物实验室（美国）

SKU-52787